Catalyst Private Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$721K Buy
601
+38
+7% +$38.8K 0.35% 45
2026
Q1
$518K Buy
563
+51
+10% +$51.7K 0.28% 48
2025
Q4
$550K Buy
512
+26
+5% +$24.9K 0.24% 48
2025
Q3
$371K Buy
486
+10
+2% +$7.44K 0.16% 63
2025
Q2
$371K Buy
476
+35
+8% +$27.2K 0.17% 62
2025
Q1
$364K Buy
441
+4
+0.9% +$3.33K 0.18% 58
2024
Q4
$337K Buy
437
+35
+9% +$29K 0.15% 67
2024
Q3
$356K Hold
402
0.17% 64
2024
Q2
$364K Buy
+402
New +$322K 0.19% 62
2020
Q4
Sell
-34
Closed -$5K 177
2020
Q3
$5K Buy
+34
New +$5.26K ﹤0.01% 240

Other funds holding LLY

Catalyst Private Wealth's LLY Position: Q2 2026 in Review

Catalyst Private Wealth increased its Eli Lilly (LLY) stake by 6.7% in Q2 2026, buying an estimated $38.8K and bringing the position to 601 shares worth $721K. The position accounts for 0.35% of the portfolio, ranked #45.

Catalyst Private Wealth first reported a position in LLY in Q3 2020 and has held it in 10 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Catalyst Private Wealth held 601 shares of Eli Lilly worth $721K as of Q2 2026.
  • Catalyst Private Wealth bought 38 Eli Lilly shares in Q2 2026, an estimated $38.8K.
  • Eli Lilly made up 0.35% of Catalyst Private Wealth's portfolio in Q2 2026, its #45 holding.
  • Catalyst Private Wealth first reported a position in Eli Lilly in Q3 2020 and has held it in 10 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Catalyst Private Wealth's 13F filing for Q2 2026, filed 21 Jul 2026.